Viewing StudyNCT00464880



Ignite Creation Date: 2024-05-05 @ 5:29 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00464880
Status: COMPLETED
Last Update Posted: 2007-11-29
First Post: 2007-04-21

Brief Title: Effects of Aliskiren Irbesartan and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Diabetes Type 2
Keywords:
Name View
Placebo-controlled study View
assess the renoprotective effect of renin inhibition View
Aliskiren as an alternative to irbesartan View
Type 2 diabetes patients View
incipientovert diabetic nephropathy View